Aerie Pharmaceuticals
Aerie Pharmaceuticals was an American clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates were once-daily therapies for lowering intraocular pressure with mechanisms to treat patients with glaucoma or ocular hypertension.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 55 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
—
not enough monitored evidence
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
12.5
confidence 55 % · cci-v1
9 active sensors·1 observation·0 historical changes·0 structured events·historical coverage 94 %·observed since 2026-09-13
Compare Aerie Pharmaceuticals with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies
